Author Guidelines

IJD SUBMISSION FORMS

Online Submission
Contact the Editorial Office

1. ABOUT IJD

Published monthly, the International Journal of Dermatology (IJD) is specifically designed to provide dermatologists around the world with a regular, up-to-date source of information on all aspects of the diagnosis and management of skin diseases. Accepted articles regularly cover clinical trials, education, morphology, pharmacology and therapeutics, case reports, and reviews. Additional features include tropical medicine reports, news, correspondence, and proceedings and transactions.

IJD is guided by a distinguished, international editorial board and emphasizes a global approach to continuing medical education for physicians and other providers of health care with a specific interest in problems relating to the skin.

2. MANUSCRIPT CATEGORIES

IJD invites the following types of submission:

Case Report*
A report of 400–600 words, illustrated by no more than three illustrations. This category offers a means for rapid communication about a single subject.

Clinical Trial
An article of 700–1200 words concerning a drug evaluation. This category provides rapid publications and is meant to be a succinct presentation with a minimum of graphs and tables.

Commentary*
An editorial 700–1200 words in length with approximately five references. The author may express his or her opinion without complete documentation.

Clinicopathological Challenge*
A photographic essay that includes both a clinical and a pathological photograph in color. The diagnosis and legends for the photographs should be listed after the references in the article. The article should be no more than 2 pages in length and contain 4-5 references.

Correspondence*
Letters to the editor and short notes. Contributions should not exceed 600 words, two figures, and 5 references. In order to offer rapid dissemination of accepted manuscripts, Correspondence items will be published online-only. Online-only correspondence items are assigned to an issue of the journal, but are excluded from the print edition. Online-only correspondence items are e-paginated and are fully citable and indexable.

Dermatological Surgery
An article relating to the surgical aspects of treatment. Article types may include Review, Report or Correspondence format.

Education
An article about the methodology of curriculum and instruction in dermatology, about 2500 words.

On a Human Scale* (by invitation only)
An article that relates to social, economic, cultural, artistic and humanitarian aspects of medicine. The length of the article should not exceed 1200 words including a short summary of the topic addressed. A brief author biography and photo should be submitted with the article. If you have a topic that you feel would fit nicely in this section, please send a note to [email protected] for approval to submit.

Pharmacology and Therapeutics
An article relating to the treatment of diseases and to the pharmacology of dermatologically-related drugs. (Can include Clinical Trials, Reviews, Reports, and Correspondence. The latter is preferred for reports of adverse drug reactions.) When referring to a drug, please use the generic name approved by the United States Food and Drug Administration or recognized as the United States Adopted Name. At the end of the manuscript, please list the American Trade names.

Report
An original article including, whenever possible, an Introduction, Materials and Methods or Case Report(s), Results, Comment, and References. A Structured Abstract of not more than 250 words must be included and should consist of four paragraphs labeled Background, Methods, Results, and Conclusions. Also, it should describe the problem studied, how the study was performed, the main results, and what the author(s) concluded from the results. The article should range from 2500-3000 words.

Review
A major didactic article that clarifies and summarizes the existing knowledge in a particular field. It should not be an exhaustive review of the literature, and references should not exceed 50 in number. Tables, diagrams, and selected figures are often helpful and preferred. The length is left to the judgment of the author, although it generally should not exceed 5000 words. Topics may include updates in clinically relevant basic science and cutaneous biology. A list of 10 multiple choice and/or true and false questions should be listed at the end of the article to provide additional educational challenge to the reader. An abstract is required, though it need not be structured.

Tropical Medicine Rounds
An article dealing with the diseases and special problems encountered by dermatologists working in the tropics. Article submissions should follow the Report, Case Report, or Correspondence format.

Updates in Medicine
This contribution to the journal should be 700–1200 words in length with sufficient references to document important points. It is not essential that the contribution be heavily referenced as it is meant to serve as an update for dermatologists in various fields of medicine and is not portrayed to be an extensive or exhaustive review of the literature. However, it would be very helpful if pertinent and salient references are included, not only for documentation purposes, but also for additional reading.

Medical Genetics
Report, Review or Correspondence format should be followed.

*No abstract required

3. SUBMISSION OF MANUSCRIPTS

Submissions should be made online at the IJD ScholarOne Manuscripts site (formerly known as Manuscript Central). New users should first create an account (do not upload document files at this time). Once a user is logged onto the site, submissions should be made via the Author Center.

Revised manuscripts must be submitted as revisions as directed by the ScholarOne website. Do not resubmit a revision as a new manuscript as this may result in re-review and considerable delay. The revision should be complete and contain all the tables and figures. Do not resubmit the original manuscript with your revision.

Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.

By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

4. PREPARATION OF MANUSCRIPTS

Manuscripts must be written in English and must comply with these instructions in every detail.

Text should be supplied in a word processed format such as Microsoft Word for Windows. Charts and tables are considered textual and should be supplied in the same format. Figures (illustrations, diagrams, photographs) should be supplied in gif, jpeg, tif or eps format.

All manuscripts must be typed in 12 pt font with lines double spaced and margins of at least 2.5 cm.

Abbreviations must be defined when first used, both in the abstract and in the main text.

Manuscripts must be as succinct as possible. Text must comply with the word and figure limits defined in Section 2. If authors consider that a manuscript should not conform to the limits specified, exceptionally good reasons must be clearly provided in a cover letter accompanying the submission. Repetition of information or data in different sections of the manuscript must be carefully avoided.

Manuscripts should, where appropriate, include:

Title Page
The first page of all manuscripts should contain the following information:
1) the title of the paper
2) surnames (family names),initials of each author, and their degree (if any)
3) name of the institution(s) at which the research was conducted
4) name, address, telephone number and email address of corresponding author
5) manuscript word count (excluding abstract and references), table and figure count
7) any conflict of interest disclosures (see Section 5)
8) a running head not exceeding 50 characters

Abstracts
Authors submitting Reports should note that structured abstracts (maximum 250 words) are required. The structured abstract should adopt the format: Background, Methods, Results, Conclusions.

Review articles require abstracts (maximum 250 words) but they need not be structured.

Abstracts should not contain citations.

Text
This should in general, but not necessarily, be divided into sections with the headings: Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables, Table and figure legends. Figures should be submitted as separate files. The acknowledgements should include a statement of all funding sources that supported the work.

Please submit the full text of the manuscript, including the abstract, references, tables and legends as a single document. The title page may be included as page 1 of the main manuscript document or can be uploaded as a separate file, but must be included.

Tables and Figures
Tables should not be inserted in the appropriate place in the text but should be included at the end of the manuscript, each on a separate page.

Figures (illustrations, diagrams, photographs) should be supplied in gif, jpeg, tif or eps format and submitted as separate electronic files.

Tables and figures should be referred to in text as follows: Fig. 1, Figs. 2–4; Table 1, Tables 2 and 3. The place at which a table or figure is to be inserted in the printed text should be indicated clearly on a manuscript. Each table and/or figure must have a legend that explains its purpose without reference to the text. Where a figure has more than one panel, each panel should be labelled in the top left-hand corner using lower case letters in parentheses i.e. ‘(a)’, ‘(b)’ etc., and a brief description of each panel given in the figure legend. When using histology figures, the stain type and magnification level must be included in the legend.

Only figures of excellent quality will be considered for publication. The Journal will publish color photographs free of charge subject to editorial approval. When an individual is identifiable in a photograph written permission must be obtained (see Section 5 ‘Ethics’ below).

Authors are themselves responsible for obtaining permission to reproduce previously published figures or tables.

References
References should be in Vancouver format and appear as consecutive, unbracketed superscript numbers in the text, e.g. ‘in our previous reports^1,2 and those of Smith et al.^3–5’ and should be listed numerically in the reference list at the end of the article.

Format references as below, using standard (Medline) abbreviations for journal titles. When there are more than six authors, include the first six authors followed by et al.

1. de Berker DAR, Baran R, Dawber RPR. The Nail in Dermatological Diseases. In: Baran and Dawber's Diseases of the Nails and their Management (Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti, A, eds), 3rd edn. Oxford: Blackwell Science Ltd., 2001: 172–92.
2. Murray ML, Cohen JB. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 2007; 32: 23–7.
3. Graham-Brown R, Burns T. Lecture Notes: Dermatology. Oxford: Wiley-Blackwell, 2006.
4. Smith A. (1999) Select committee report into social care in the community [WWW document]. URL http://www.dhss.gov.uk/reports/report015285.html [accessed on 7 November 2003].

5. DECLARATIONS

Original Publication
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.

Conflicts of Interest
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived by others as biasing their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist.

Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. A statement describing explicitly the ethical background to the studies being reported should be included in all manuscripts in the Materials and Methods section. Ethics committee or institutional review board approval should be stated.

Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Authorship
All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.

Committee on Publication Ethics (COPE)
As a member of the Committee on Publication Ethics (COPE), adherence to these submission criteria is considered essential for publication in IJD; mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript or authors are found to have disregarded these criteria, it is the duty of the Editor to report this to COPE. COPE may recommend that action be taken, including but not exclusive to, informing the authors' professional regulatory body and/or institution of such a dereliction.

The website for COPE may be accessed at: http://www.publicationethics.org.uk

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

6. ADDITIONAL INFORMATION ON ACCEPTANCE

Author services
Author Services enables authors to track their article—once it has been accepted—through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the open access in hybrid titles option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below: CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing open access in hybrid titles

If the open access in hybrid titles option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial - NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the open access in hybrid titles option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

Proofs
The corresponding author will receive an email alert containing a link to a web site. Please answer all queries and update the text as required.

Early View
IJD is covered by the Publisher's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found online at http://www.doi.org/faq.html.

Offprints
Free access to the final PDF offprint of your article will be available via Author Services only.

Should you wish to purchase additional copies of your article, please click on the link and follow the instructions provided:
www.sheridan.com/wiley/eoc

Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see http://www.wiley.com/go/nihmandate.

Contacting the Editorial Office
Professor Rokea A. el-Azhary
Editor-in-Chief
Mayo Clinic E-5A
200 First Street SW
Rochester MN 55905
USA
Tel: +1 507 538-8249
Fax: +1 507 284 2072
E-mail: [email protected]